PHARVARIS NV (PHVS) Stock Price, Quote, News and Overview
NASDAQ:PHVS - Nasdaq - NL00150005Y4 - Common Stock - Currency: USD
PHVS Quote, Performance and Key Statistics
NASDAQ:PHVS (4/17/2025, 8:00:00 PM)
14
+0.28 (+2.04%)
The current stock price of PHVS is 14 USD. In the past month the price decreased by -9.44%. In the past year, price decreased by -26.93%.
PHVS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 64.61 | 796.27B | ||
| JNJ | JOHNSON & JOHNSON | 15.67 | 379.48B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 16.83 | 257.82B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.96 | 218.96B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.29 | 209.55B | ||
| MRK | MERCK & CO. INC. | 10.21 | 196.28B | ||
| PFE | PFIZER INC | 7.12 | 125.57B | ||
| SNY | SANOFI-ADR | 11.41 | 124.61B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 43.18 | 100.17B | ||
| GSK | GSK PLC-SPON ADR | 8.3 | 72.81B | ||
| ZTS | ZOETIS INC | 25.11 | 66.32B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.98 | 46.30B |
Related stock screener links
About PHVS
Company Profile
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. The company is headquartered in Leiden, Zuid-Holland and currently employs 82 full-time employees. The company went IPO on 2021-02-05. The firm focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. The company is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The firm is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.
Company Info
PHARVARIS NV
Emmy Noetherweg 2
Leiden ZUID-HOLLAND NL
CEO: Berndt Modig
Employees: 83
Company Website: https://pharvaris.com/
Investor Relations: http://ir.pharvaris.com
Phone: 31712036410
PHARVARIS NV / PHVS FAQ
What is the stock price of PHARVARIS NV today?
The current stock price of PHVS is 14 USD. The price increased by 2.04% in the last trading session.
What is the ticker symbol for PHARVARIS NV stock?
The exchange symbol of PHARVARIS NV is PHVS and it is listed on the Nasdaq exchange.
On which exchange is PHVS stock listed?
PHVS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PHARVARIS NV stock?
14 analysts have analysed PHVS and the average price target is 35.7 USD. This implies a price increase of 155% is expected in the next year compared to the current price of 14. Check the PHARVARIS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PHARVARIS NV worth?
PHARVARIS NV (PHVS) has a market capitalization of 762.86M USD. This makes PHVS a Small Cap stock.
How many employees does PHARVARIS NV have?
PHARVARIS NV (PHVS) currently has 83 employees.
What are the support and resistance levels for PHARVARIS NV (PHVS) stock?
PHARVARIS NV (PHVS) has a support level at 11.99 and a resistance level at 14.01. Check the full technical report for a detailed analysis of PHVS support and resistance levels.
Should I buy PHARVARIS NV (PHVS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PHVS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PHVS, evaluating the profitability, health, valuation and growth aspects
- PHARVARIS NV (PHVS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PHARVARIS NV (PHVS) Sales and EPS estimates to see what analysts future expectations are.
- PHARVARIS NV (PHVS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PHARVARIS NV (PHVS) Insider and Institutional Ownership to learn about the owners and their transactions.
- PHARVARIS NV (PHVS) Stock Chart to make your own analysis
- PHARVARIS NV (PHVS) Latest news and press-releases to stay up to date.
Does PHARVARIS NV (PHVS) stock pay dividends?
PHVS does not pay a dividend.
When does PHARVARIS NV (PHVS) report earnings?
PHARVARIS NV (PHVS) will report earnings on 2025-05-07, after the market close.
What is the Price/Earnings (PE) ratio of PHARVARIS NV (PHVS)?
PHARVARIS NV (PHVS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.82).
What is the Short Interest ratio of PHARVARIS NV (PHVS) stock?
The outstanding short interest for PHARVARIS NV (PHVS) is 1.5% of its float. Check the ownership tab for more information on the PHVS short interest.
PHVS Technical Analysis
PHVS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PHVS. PHVS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
PHVS Financial Highlights
Over the last trailing twelve months PHVS reported a non-GAAP Earnings per Share(EPS) of -2.82. The EPS increased by 6.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.06% | ||
| ROE | -50.13% | ||
| Debt/Equity | 0 |
PHVS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to PHVS. The Buy consensus is the average rating of analysts ratings from 14 analysts.